DAVENPORT & Co LLC Sells 84,524 Shares of HealthEquity, Inc. (NASDAQ:HQY)

DAVENPORT & Co LLC decreased its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 17.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 395,889 shares of the company's stock after selling 84,524 shares during the period. DAVENPORT & Co LLC owned 0.46% of HealthEquity worth $38,252,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. KBC Group NV raised its holdings in HealthEquity by 56.7% during the fourth quarter. KBC Group NV now owns 3,860 shares of the company's stock valued at $370,000 after buying an additional 1,397 shares in the last quarter. Curated Wealth Partners LLC acquired a new stake in HealthEquity during the fourth quarter valued at approximately $242,000. Exchange Traded Concepts LLC boosted its holdings in HealthEquity by 2.6% during the fourth quarter. Exchange Traded Concepts LLC now owns 9,813 shares of the company's stock valued at $942,000 after purchasing an additional 245 shares in the last quarter. Janney Montgomery Scott LLC boosted its holdings in HealthEquity by 8.5% during the fourth quarter. Janney Montgomery Scott LLC now owns 5,352 shares of the company's stock valued at $514,000 after purchasing an additional 420 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its holdings in HealthEquity by 8.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 3,719 shares of the company's stock valued at $357,000 after purchasing an additional 299 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Trading Down 1.4 %

NASDAQ HQY traded down $1.58 during mid-day trading on Wednesday, reaching $110.40. 694,811 shares of the stock were exchanged, compared to its average volume of 738,112. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $113.22. The stock has a 50 day simple moving average of $100.39 and a 200-day simple moving average of $89.02. The stock has a market cap of $9.57 billion, a P/E ratio of 101.15, a P/E/G ratio of 1.94 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the prior year, the company earned $0.40 earnings per share. On average, analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction on Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the completion of the sale, the director now owns 66,469 shares of the company's stock, valued at $6,750,591.64. This represents a 11.04 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the firm's stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the sale, the director now directly owns 19,061 shares of the company's stock, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Royal Bank of Canada boosted their target price on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a report on Tuesday, December 10th. Barrington Research upped their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Monday, December 2nd. Mizuho assumed coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price objective for the company. The Goldman Sachs Group started coverage on shares of HealthEquity in a research report on Friday, November 15th. They issued a "neutral" rating and a $108.00 price objective for the company. Finally, BTIG Research upped their target price on shares of HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research note on Thursday, November 14th. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $110.71.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.